June 22nd, 2010
 |
“After clinical trials are complete, Asacol treatment for inflammatory bowel disease will be available.” |
Asacol, an anti-inflammatory prescription drug, is typically prescribed for treatment of ulcerative colitis. New research suggests that Asacol can also work as drug treatment for inflammatory bowel disease (IBD).
Asacol is an oral enteric-coated pharmaceutical formulation of mesalazine, which can be used as a treatment for inflammatory bowel disease. Asacol has been exclusively licensed since 2004 by Tillotts Pharma AG in Switzerland.
A new agreement has been made that allows clinical trials of treatment for inflammatory bowel disease that will be paid for by Zeria. The trials will include a clinical development for ulcerative colitis treatment and Chrohn’s disease.
After clinical trials are complete, Asacol treatment for inflammatory bowel disease will be available.

For more information on purchasing Asacol treatment for inflammatory bowel disease, visit http://www.orderonlinedrugs.com